表皮生长因子受体激活刺激损伤的肾近端小管上皮细胞中SOX9表达
研究在急性肾小管损伤或慢性移植肾病早期患者肾小管上皮细胞中检测到SOX9与EGFR表达升高并共定位,并通过多种小鼠模型及培养人肾近端小管上皮细胞证实EGFR激活经Akt–YAP/TAZ–TEAD通路诱导SOX9表达。
要点
- 损伤的肾近端小管上皮细胞中EGFR与SOX9表达升高并共定位。
- 小鼠中遗传或药物抑制EGFR可阻断缺血性损伤后SOX9上调。
- 抑制YAP/TAZ–TEAD可阻断缺血性AKI或EGF刺激引起的SOX9上调。
核心结论
- EGFR激活对于AKI后肾近端小管上皮细胞中SOX9表达至关重要。
研究设计与样本
- 检测急性肾小管损伤或慢性移植肾病早期患者肾小管上皮细胞中SOX9与EGFR表达。
- 使用不同小鼠模型研究EGFR激活在调控损伤肾近端小管上皮细胞SOX9上调中的作用。
- 在培养的人肾近端小管上皮细胞中进一步证实EGFR激活上调SOX9表达的机制。
主要发现
- 在急性肾小管损伤或慢性移植肾病早期患者肾小管上皮细胞中检测到SOX9与EGFR表达升高并共定位。
- 小鼠肾近端小管上皮细胞过表达人肝素结合EGF导致SOX9表达增加,与EGFR酪氨酸激酶缺陷的waved2小鼠杂交后该增加被消除。
- 遗传或药物抑制EGFR导致缺血性AKI后肾小管细胞中SOX9表达减少。
- 缺血性AKI激活近端小管EGFR,导致Akt–YAP/TAZ–TEAD通路激活及随后SOX9诱导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Upregulation and colocalization of EGF receptor and SOX9 were exhibited in injured renal proximal tubule epithelial cells (RPTCs). Genetic or pharmacologic inhibition of EGF receptor activation in mice blocked SOX9 upregulation in the ischemic injured RPTCs. Inhibition of yes-associated protein/transcriptional coactivator with PDZ-binding motif–transcriptional enhanced associate domain in mice or cultured RPTCs blocked SOX9 upregulation in response to ischemic AKI or EGF treatment. BACKGROUND: In surviving renal proximal tubule cells (RPTCs) after AKI, the induction of SOX9 expression plays a crucial role in promoting kidney repair. However, persistent upregulation of SOX9 in RPTCs contributes to the development of CKD. The molecular mechanisms underlying SOX9 induction in response to kidney injury are not completely understood. We and others have previously reported that the activation of EGF receptor (EGFR) in RPTCs can accelerate kidney recovery from ischemic injury, but persistent EGFR activation leads to tubulointerstitial fibrosis. METHODS: We examined SOX9 and EGFR expression in renal tubular epithelial cells of patients with acute tubular injury or early stages of chronic allograft nephropathy. We investigated the role of EGFR activation in regulating SOX9 upregulation in injured RPTCs using different mouse models. We further confirmed the underlying mechanism by which EGFR activation upregulates SOX9 expression in cultured human RPTCs. RESULTS: Elevation and colocalization of SOX9 and EGFR expression were detected in renal tubular epithelial cells of patients with acute tubular injury or early stages of chronic allograft nephropathy. Overexpression of human heparin-binding EGF in RPTC of mice led to increased SOX9 expression, which was abolished when these mice were crossed with EGFR tyrosine kinase–deficient waved2 mice. Genetic or pharmacologic inhibition of EGFR resulted in decreased SOX9 expression in renal tubular cells in response to ischemic AKI. Mechanistically, ischemic AKI activates proximal tubule EGFR, leading to the activation of Akt–yes-associated protein/transcriptional coactivator with PDZ-binding motif–transcriptional enhanced associate domain pathway and the subsequent induction of SOX9. CONCLUSIONS: EGFR activation is crucial for SOX9 expression in RPTCs after AKI.
引用
- Chen J, Peng F, Jiang M, et al. EGF Receptor Activation Stimulates SOX9 Expression in Injured Renal Proximal Tubule Epithelial Cells. J Am Soc Nephrol. 2025. PMID: 40892469. doi:10.1681/ASN.0000000830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。